BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38003943)

  • 1. Flash Glucose Monitoring in Croatia: The Optimal Number of Scans per Day to Achieve Good Glycemic Control in Type 1 Diabetes.
    Canecki-Varzic S; Prpic-Krizevac I; Cigrovski Berkovic M; Rahelic D; Schonberger E; Gradiser M; Bilic-Curcic I
    Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003943
    [No Abstract]   [Full Text] [Related]  

  • 2. Flash glucose monitoring and glycemic control in type 1 diabetes with subcutaneous insulin infusion.
    Pinheiro SL; Bastos M; Barros L; Melo M; Paiva I
    Acta Diabetol; 2022 Apr; 59(4):509-515. PubMed ID: 34786633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittently Scanned Continuous Glucose Monitoring Data of Polish Patients from Real-Life Conditions: More Scanning and Better Glycemic Control Compared to Worldwide Data.
    Hohendorff J; Gumprecht J; Mysliwiec M; Zozulinska-Ziolkiewicz D; Malecki MT
    Diabetes Technol Ther; 2021 Aug; 23(8):577-585. PubMed ID: 33794101
    [No Abstract]   [Full Text] [Related]  

  • 4. Flash Glucose Monitoring in Israel: Understanding Real-World Associations between Self-Monitoring Frequency and Metrics of Glycemic Control.
    Eldor R; Roitman E; Merzon E; Toledano Y; Alves C; Tsur A
    Endocr Pract; 2022 May; 28(5):472-478. PubMed ID: 35167952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scans per day as predictors of optimal glycemic control in people with type 1 diabetes mellitus using flash glucose monitoring: what number of scans per day should raise a red flag?
    Sebastian-Valles F; Martínez-Alfonso J; Arranz Martin JA; Jiménez-Díaz J; Hernando Alday I; Navas-Moreno V; Armenta Joya T; Fandiño García MDM; Román Gómez GL; Lander Lobariñas LE; Martinez de Icaya P; Sampedro-Nuñez MA; Martínez-Vizacaíno V; Marazuela M
    Acta Diabetol; 2024 Mar; 61(3):343-350. PubMed ID: 37930420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher scanning frequency is correlated with less fear of hypoglycemia in type 1 diabetes patients using isCGM.
    Hohendorff J; Witek P; Kania M; Sudol M; Hajduk K; Stepien A; Cyganek K; Kiec-Wilk B; Klupa T; Malecki MT
    Front Endocrinol (Lausanne); 2022; 13():996933. PubMed ID: 36277730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life 24-week changes in glycemic parameters among European users of flash glucose monitoring with type 1 and 2 diabetes and different levels of glycemic control.
    Lameijer A; Bakker JJ; Kao K; Xu Y; Gans ROB; Bilo HJG; Dunn TC; van Dijk PR
    Diabetes Res Clin Pract; 2023 Jul; 201():110735. PubMed ID: 37276981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
    Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of use and improvement in glycemic indices after initiating continuous glucose monitoring in real world: Data from Saudi Arabia.
    Alyusuf EY; Alharthi S; Alguwaihes AM; Jammah AA; Alfadda AA; Al-Sofiani ME
    Diabetes Metab Syndr; 2022 Feb; 16(2):102416. PubMed ID: 35150962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Frequency of Intermittently Scanned Glucose and Diurnal Variation of Glycemic Metrics.
    Hansen KW; Bibby BM
    J Diabetes Sci Technol; 2022 Nov; 16(6):1461-1465. PubMed ID: 34041961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump.
    Al Hayek AA; Robert AA; Al Dawish MA
    Diabetes Metab Syndr; 2021; 15(5):102265. PubMed ID: 34488057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of unblinded and blinded intermittently scanned continuous glucose monitoring for glycemic control in adults with type 1 diabetes.
    Guo L; Li Y; Zhang M; Xiao X; Kuang H; Yang T; Jia X; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1110845. PubMed ID: 36909344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of switch from flash glucose monitoring to flash glucose monitoring with real-time alarms on hypoglycaemia in people with type 1 diabetes mellitus.
    Gutiérrez-Pastor A; Quesada JA; Soler-Martínez MM; Carratalá Munuera C; Pomares-Gómez FJ
    Prim Care Diabetes; 2024 Jun; 18(3):333-339. PubMed ID: 38677966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life.
    Duarte DB; Fonseca L; Santos T; Silva VB; Puga FM; Saraiva M; Silva IL; Teixeira S; Vilaverde J; Cardoso MH
    Diabetes Metab Syndr; 2022 Jun; 16(6):102509. PubMed ID: 35598543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
    Ajjan RA; Heller SR; Everett CC; Vargas-Palacios A; Higham R; Sharples L; Gorog DA; Rogers A; Reynolds C; Fernandez C; Rodrigues P; Sathyapalan T; Storey RF; Stocken DD
    Diabetes Care; 2023 Feb; 46(2):441-449. PubMed ID: 36516054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
    Oriot P; Hermans MP
    J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study.
    Calhoun P; Price D; Beck RW
    Diabetes Technol Ther; 2021 Mar; 23(3):230-233. PubMed ID: 33006904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.